NexImmune analyst ratings
NexImmune analyst ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
06/01/2022 | 119.3% | BTIG | → $5 | Initiates Coverage On | → Buy |
04/01/2022 | 207.02% | Barclays | $4 → $7 | Maintains | Overweight |
02/22/2022 | 470.18% | Raymond James | $21 → $13 | Maintains | Outperform |
11/15/2021 | 821.05% | Raymond James | $30 → $21 | Maintains | Outperform |
04/01/2021 | 1215.79% | Raymond James | → $30 | Initiates Coverage On | → Outperform |
03/09/2021 | 1435.09% | Cantor Fitzgerald | → $35 | Initiates Coverage On | → Overweight |
日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
---|---|---|---|---|---|
2022 年 1 月 6 日 | 119.3% | BTIG | → 5 美元 | 啓動覆蓋範圍開啓 | → 購買 |
04/01/2022 | 207.02% | 巴克萊 | 4 美元 → 7 美元 | 維護 | 超重 |
02/22/2022 | 470.18% | 雷蒙德·詹姆 | 21 美元 → 13 美元 | 維護 | 跑贏大盤 |
11/15/2021 | 821.05% | 雷蒙德·詹姆 | 30 美元 → 21 美元 | 維護 | 跑贏大盤 |
2021 年 1 月 4 日 | 1215.79% | 雷蒙德·詹姆 | → 30 美元 | 啓動覆蓋範圍開啓 | → 跑贏大盤 |
2021 年 9 月 3 日 | 1435.09% | 坎託·菲茨傑拉德 | → 35 美元 | 啓動覆蓋範圍開啓 | → 超重 |
NexImmune Questions & Answers
nexImmune 問答
The latest price target for NexImmune (NASDAQ: NEXI) was reported by BTIG on June 1, 2022. The analyst firm set a price target for $5.00 expecting NEXI to rise to within 12 months (a possible 119.30% upside). 4 analyst firms have reported ratings in the last year.
BTIG於2022年6月1日公佈了NexImmune(納斯達克股票代碼:NEXI)的最新目標股價。該分析公司將目標股價定爲5.00美元,預計NEXI將在12個月內升至12個月內(可能上漲119.30%)。去年有4家分析公司公佈了評級。
The latest analyst rating for NexImmune (NASDAQ: NEXI) was provided by BTIG, and NexImmune initiated their buy rating.
BTIG提供了NexImmune(納斯達克股票代碼:NEXI)的最新分析師評級,NexImmune啓動了買入評級。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of NexImmune, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for NexImmune was filed on June 1, 2022 so you should expect the next rating to be made available sometime around June 1, 2023.
分析師在進行了廣泛的研究後得出了股票評級,其中包括瀏覽公開財務報表,與NexImmune的高管和客戶交談,以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級,因此每家公司每年應該獲得4次評級。NexImmune 的最新評級是在 2022 年 6 月 1 日公佈的,因此您應該預計,下一個評級將在 2023 年 6 月 1 日左右公佈。
While ratings are subjective and will change, the latest NexImmune (NEXI) rating was a initiated with a price target of $0.00 to $5.00. The current price NexImmune (NEXI) is trading at is $2.28, which is within the analyst's predicted range.
儘管評級是主觀的,並且會發生變化,但最新的NexImmune(NEXI)評級最初是以0.00美元至5.00美元的目標股價爲起步的。NexImmune(NEXI)目前的交易價格爲2.28美元,在分析師的預測區間內。